ZFPM2 (Zinc Finger Protein, FOG Family Member 2) antibodies are specialized tools designed to detect and analyze the ZFPM2 protein, a transcription factor critical for developmental processes such as cardiogenesis, lung morphogenesis, and gonadal differentiation . These antibodies are widely used in research to study ZFPM2's role in diseases, including cancer and congenital disorders .
ZFPM2 (FOG2) interacts with GATA family transcription factors to regulate gene expression . Dysregulation is linked to congenital heart defects, diaphragmatic hernias, and disorders of sex development .
ZFPM2 antibodies have been pivotal in elucidating oncogenic roles of ZFPM2-AS1 (a ZFPM2-associated lncRNA) in cancers:
Thyroid Cancer: ZFPM2-AS1 knockdown reduced proliferation, migration, and epithelial-mesenchymal transition (EMT) in SW579 and 8505C cells .
Lung Adenocarcinoma: ZFPM2-AS1 promoted tumor progression via UPF1-mediated ZFPM2 mRNA decay .
46,XY DSD: Variants in ZFPM2 were identified in patients with hypospadias or ambiguous genitalia, though most were benign .
Cardiac Defects: ZFPM2 antibodies validated its role in heart morphogenesis via GATA4 interaction .
Commercial ZFPM2 antibodies undergo rigorous validation:
Western Blot: Detects ~39–165 kDa bands (varies by isoform) .
IHC/IF: Confirmed reactivity in human breast cancer and cardiac tissues .